Mallinath B. Hadimani

639 total citations
17 papers, 535 citations indexed

About

Mallinath B. Hadimani is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Mallinath B. Hadimani has authored 17 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Mallinath B. Hadimani's work include Synthesis and biological activity (6 papers), Influenza Virus Research Studies (3 papers) and Immune Response and Inflammation (3 papers). Mallinath B. Hadimani is often cited by papers focused on Synthesis and biological activity (6 papers), Influenza Virus Research Studies (3 papers) and Immune Response and Inflammation (3 papers). Mallinath B. Hadimani collaborates with scholars based in United States, Sweden and India. Mallinath B. Hadimani's co-authors include Kevin G. Pinney, S. Bruce King, Mary Lynn Trawick, Vikas Kumar, Amitabha Dey, George R. Pettit, C. Michael Garner, David J. Chaplin, Klaus Edvardsen and Beth C. Holbrook and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Cancer Letters.

In The Last Decade

Mallinath B. Hadimani

17 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mallinath B. Hadimani United States 14 206 155 63 60 60 17 535
Thadeu Estevam Moreira Maramaldo Costa Brazil 13 180 0.9× 225 1.5× 56 0.9× 57 0.9× 60 1.0× 21 574
Partha Palit India 14 96 0.5× 124 0.8× 34 0.5× 74 1.2× 33 0.6× 36 473
En‐Shyh Lin Taiwan 18 81 0.4× 401 2.6× 67 1.1× 57 0.9× 34 0.6× 52 869
S. A. Dhanaraj India 9 79 0.4× 163 1.1× 47 0.7× 39 0.7× 30 0.5× 19 505
Alexandra Mioc Romania 16 93 0.5× 325 2.1× 59 0.9× 17 0.3× 42 0.7× 46 664
Fuqian Wang China 14 110 0.5× 213 1.4× 52 0.8× 32 0.5× 36 0.6× 35 598
Teresa Pecere Italy 5 81 0.4× 193 1.2× 56 0.9× 50 0.8× 42 0.7× 6 528
Konrad Kubiński Poland 15 302 1.5× 329 2.1× 39 0.6× 33 0.6× 20 0.3× 45 748
Mohamed F. Abdelhameed Egypt 15 158 0.8× 189 1.2× 31 0.5× 27 0.5× 19 0.3× 64 615
Tae Hyung Won South Korea 16 111 0.5× 291 1.9× 23 0.4× 20 0.3× 102 1.7× 27 631

Countries citing papers authored by Mallinath B. Hadimani

Since Specialization
Citations

This map shows the geographic impact of Mallinath B. Hadimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallinath B. Hadimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallinath B. Hadimani more than expected).

Fields of papers citing papers by Mallinath B. Hadimani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallinath B. Hadimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallinath B. Hadimani. The network helps show where Mallinath B. Hadimani may publish in the future.

Co-authorship network of co-authors of Mallinath B. Hadimani

This figure shows the co-authorship network connecting the top 25 collaborators of Mallinath B. Hadimani. A scholar is included among the top collaborators of Mallinath B. Hadimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallinath B. Hadimani. Mallinath B. Hadimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Holbrook, Beth C., Ralph B. D’Agostino, Matthew J. Jorgensen, et al.. (2017). Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6 months in a nonhuman primate neonate model. Vaccine. 35(45). 6137–6142. 20 indexed citations
2.
Holbrook, Beth C., et al.. (2017). An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non‐human primate neonates. Immunology. 153(3). 357–367. 24 indexed citations
3.
Holbrook, Beth C., Jongrok Kim, Lance K. Blevins, et al.. (2016). A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model. The Journal of Immunology. 197(2). 555–564. 31 indexed citations
4.
Hadimani, Mallinath B., et al.. (2015). Ring expansions of acyloxy nitroso compounds. Tetrahedron Letters. 56(43). 5870–5873. 11 indexed citations
5.
Kumar, Vikas, et al.. (2015). Chemistry and pharmacology of withania somnifera. 5(1). 1–13. 12 indexed citations
6.
Fahrenholtz, Cale D., Mallinath B. Hadimani, S. Bruce King, Suzy V. Torti, & Ravi Singh. (2015). Targeting Breast Cancer with Sugar-Coated Carbon Nanotubes. Nanomedicine. 10(16). 2481–2497. 33 indexed citations
7.
Strecker, Tracy E., Ramona Lopez, Li Li, et al.. (2015). The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts. Cancer Letters. 369(1). 229–241. 33 indexed citations
8.
Kumar, Vikas, et al.. (2015). Chemistry and pharmacology of withania somnifera: An update. 5(1). 1.1–1.13. 64 indexed citations
9.
Hadimani, Mallinath B., Anjan Ghatak, Tracy E. Strecker, et al.. (2013). Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent. Journal of Natural Products. 76(9). 1668–1678. 59 indexed citations
10.
Hadimani, Mallinath B., et al.. (2013). Guaifenesin Derivatives Promote Neurite Outgrowth and Protect Diabetic Mice from Neuropathy. Journal of Medicinal Chemistry. 56(12). 5071–5078. 14 indexed citations
11.
Wigle, Tim J., Jonathan Z. Sexton, Anna V. Gromova, et al.. (2009). Inhibitors of RecA Activity Discovered by High-Throughput Screening: Cell-Permeable Small Molecules Attenuate the SOS Response in Escherichia coli. SLAS DISCOVERY. 14(9). 1092–1101. 48 indexed citations
12.
Hadimani, Mallinath B., et al.. (2009). Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1P. Journal of Natural Products. 72(3). 414–421. 24 indexed citations
13.
Strecker, Tracy E., G.D. Kishore Kumar, Mallinath B. Hadimani, et al.. (2008). Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4. Bioorganic & Medicinal Chemistry Letters. 18(18). 5146–5149. 19 indexed citations
14.
Hadimani, Mallinath B., Jean‐Charles Chapuis, George R. Pettit, et al.. (2008). Combretastatin Dinitrogen-Substituted Stilbene Analogues as Tubulin-Binding and Vascular-Disrupting Agents. Journal of Natural Products. 71(3). 313–320. 39 indexed citations
15.
Hadimani, Mallinath B., Klaus Edvardsen, Mary Lynn Trawick, et al.. (2006). Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents. Bioorganic & Medicinal Chemistry. 14(9). 3231–3244. 68 indexed citations
16.
Hadimani, Mallinath B., Jianyi Hua, Yezhou Sheng, et al.. (2003). Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4. Bioorganic & Medicinal Chemistry Letters. 13(9). 1505–1508. 24 indexed citations
17.
Hadimani, Mallinath B., J.A. Kautz, Anjan Ghatak, et al.. (2002). 2-(3-tert-Butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4,5-trimethoxybenzoyl)indole. Acta Crystallographica Section C Crystal Structure Communications. 58(6). o330–o332. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026